申请人:Boehringer Ingelheim International GmbH
公开号:US20180186774A1
公开(公告)日:2018-07-05
The present invention relates to compounds of formula (I)
wherein R
1
, R
2
, and Z
−
have one of the meanings as indicated in the specification or a pharmaceutically acceptable salt thereof, to the use of compounds of formula (I) as a medicament, to pharmaceutical composition comprising at least one compound of formula (I), as well as to medicament combinations containing one or more compounds of formula (I).